ABVC BIOPHARMA, INC. (ABVC): Form 8-K filed 2026-08-27

Items reported

Item 1.01: Entry into a Material Definitive Agreement
The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements.
Item 2.01: Completion of Acquisition or Disposition of Assets
The company completed the acquisition or disposition of a significant amount of assets, including a business. The report covers the date, the assets, the counterparty and the consideration.
Item 7.01: Regulation FD Disclosure
The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed".
Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

Type	Description	Document
8-K	CURRENT REPORT	ea0302908-8k_abvc.htm
EX-2.1	SEPARATION AND DISTRIBUTION AGREEMENT, DATED AS OF JUNE 22, 2026, BY AND BETWEEN	ea030290801ex2-1.htm
EX-10.1	TRANSITIONAL SERVICES AGREEMENT, DATED AS OF JUNE 22, 2026, BY AND BETWEEN ABVC	ea030290801ex10-1.htm
EX-10.2	TAX MATTERS AGREEMENT, DATED AS OF JUNE 22, 2026, BY AND BETWEEN ABVC BIOPHARMA,	ea030290801ex10-2.htm
EX-10.3	EMPLOYEE MATTERS AGREEMENT, DATED AS OF JUNE 22, 2026, BY AND BETWEEN ABVC BIOPH	ea030290801ex10-3.htm

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.